Hollencrest Capital Management Guardant Health, Inc. Transaction History
Hollencrest Capital Management
- $2.2 Billion
- Q1 2025
A detailed history of Hollencrest Capital Management transactions in Guardant Health, Inc. stock. As of the latest transaction made, Hollencrest Capital Management holds 460 shares of GH stock, worth $20,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
460Holding current value
$20,263% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
391Shares Held
120MCall Options Held
1.18MPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$532 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$495 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$283 Million8.64% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$230 Million9.25% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$227 Million0.04% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.5B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...